Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 919

1.

Rapid alterations in MR imaging in MELAS syndrome.

Doppler CEJ, Kabbasch C, Fink GR, Lehmann HC, Wunderlich G.

Pract Neurol. 2019 Jul 10. pii: practneurol-2019-002266. doi: 10.1136/practneurol-2019-002266. [Epub ahead of print] No abstract available.

PMID:
31292237
2.

Processing Pipeline for Atlas-Based Imaging Data Analysis of Structural and Functional Mouse Brain MRI (AIDAmri).

Pallast N, Diedenhofen M, Blaschke S, Wieters F, Wiedermann D, Hoehn M, Fink GR, Aswendt M.

Front Neuroinform. 2019 Jun 4;13:42. doi: 10.3389/fninf.2019.00042. eCollection 2019.

3.

Deficient allo-centric visuospatial processing contributes to apraxic deficits in sub-acute right hemisphere stroke.

Ubben SD, Fink GR, Kaesberg S, Kalbe E, Kessler J, Vossel S, Weiss PH.

J Neuropsychol. 2019 Jun 17. doi: 10.1111/jnp.12191. [Epub ahead of print]

PMID:
31207114
4.

Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.

Werner JM, Stoffels G, Lichtenstein T, Borggrefe J, Lohmann P, Ceccon G, Shah NJ, Fink GR, Langen KJ, Kabbasch C, Galldiks N.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1889-1901. doi: 10.1007/s00259-019-04384-7. Epub 2019 Jun 15.

PMID:
31203420
5.

Level of education mitigates the impact of tau pathology on neuronal function.

Hoenig MC, Bischof GN, Onur ÖA, Kukolja J, Jessen F, Fliessbach K, Neumaier B, Fink GR, Kalbe E, Drzezga A, van Eimeren T; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1787-1795. doi: 10.1007/s00259-019-04342-3. Epub 2019 Jun 10.

PMID:
31183635
6.

Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.

Gerner ST, Kuramatsu JB, Sembill JA, Sprügel MI, Hagen M, Knappe RU, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Müllges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stösser S, Neugebauer H, Röther J, Michels P, Schwarz M, Reimann G, Bäzner H, Schwert H, Claßen J, Michalski D, Grau A, Palm F, Urbanek C, Wöhrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Günther A, Hamann GF, Engelhorn T, Lücking H, Dörfler A, Schwab S, Huttner HB.

Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.

PMID:
31092170
7.

Author response: DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial.

Barbe MT, Reker P, Hamacher S, Franklin J, Kraus D, Dembek TA, Becker J, Steffen JK, Allert N, Wirths J, Dafsari HS, Voges J, Fink GR, Visser-Vandewalle V, Timmermann L.

Neurology. 2019 May 14;92(20):975-976. doi: 10.1212/WNL.0000000000007521. No abstract available.

PMID:
31085731
8.

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET - Clinical relevance in glioma patients.

Galldiks N, Unterrainer M, Judov N, Stoffels G, Rapp M, Lohmann P, Vettermann F, Dunkl V, Suchorska B, Tonn JC, Kreth FW, Fink GR, Bartenstein P, Langen KJ, Albert NL.

Neuro Oncol. 2019 May 11. pii: noz083. doi: 10.1093/neuonc/noz083. [Epub ahead of print]

PMID:
31077276
9.

Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage.

Sprügel MI, Sembill JA, Kuramatsu JB, Gerner ST, Hagen M, Roeder SS, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Muellges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Wöpking S, Ludolph AC, Stösser S, Neugebauer H, Röther J, Michels P, Schwarz M, Reimann G, Bäzner H, Schwert H, Classen J, Michalski D, Grau A, Palm F, Urbanek C, Wöhrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Guenther A, Hamann GF, Lücking H, Dörfler A, Schwab S, Huttner HB.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):783-791. doi: 10.1136/jnnp-2018-319786. Epub 2019 Apr 16.

PMID:
30992334
10.

Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis.

Schweitzer F, Laurent S, Fink GR, Barnett MH, Reddel S, Hartung HP, Warnke C.

Curr Opin Neurol. 2019 Jun;32(3):305-312. doi: 10.1097/WCO.0000000000000701.

PMID:
30985373
11.

Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid Glioblastoma.

Werner JM, Brunn A, Fink GR, Galldiks N.

World Neurosurg. 2019 Jul;127:213-215. doi: 10.1016/j.wneu.2019.04.025. Epub 2019 Apr 8.

PMID:
30974270
12.

Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown Epitope.

Edwin Thanarajah S, Prüss H, Warnke C, Barbe MT, Schroeter M, Fink GR, Onur OA.

Front Neurol. 2019 Mar 5;10:175. doi: 10.3389/fneur.2019.00175. eCollection 2019.

13.

Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism.

Sommerauer M, Galldiks N, Barbe MT, Stoffels G, Willuweit A, Coenen HH, Schroeter M, Timmermann L, Fink GR, Langen KJ.

Nucl Med Commun. 2019 Apr;40(4):383-387. doi: 10.1097/MNM.0000000000000982.

PMID:
30875335
14.

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma.

Werner JM, Schweinsberg V, Schroeter M, von Reutern B, Malter MP, Schlaak M, Fink GR, Mauch C, Galldiks N.

Front Oncol. 2019 Feb 14;9:84. doi: 10.3389/fonc.2019.00084. eCollection 2019.

15.

Substrate elasticity induces quiescence and promotes neurogenesis of primary neural stem cells-A biophysical in vitro model of the physiological cerebral milieu.

Blaschke S, Vay SU, Pallast N, Rabenstein M, Abraham JA, Linnartz C, Hoffmann M, Hersch N, Merkel R, Hoffmann B, Fink GR, Rueger MA.

J Tissue Eng Regen Med. 2019 Jun;13(6):960-972. doi: 10.1002/term.2838. Epub 2019 May 21.

PMID:
30815982
16.

Age-related changes in Bayesian belief updating during attentional deployment and motor intention.

Mengotti P, Kuhns AB, Fink GR, Vossel S.

Psychol Res. 2019 Feb 26. doi: 10.1007/s00426-019-01154-w. [Epub ahead of print]

PMID:
30806810
17.

Complex modifier landscape underlying genetic background effects.

Hou J, Tan G, Fink GR, Andrews BJ, Boone C.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5045-5054. doi: 10.1073/pnas.1820915116. Epub 2019 Feb 25.

18.

Reconstruction of effective connectivity in the case of asymmetric phase distributions.

Yeldesbay A, Fink GR, Daun S.

J Neurosci Methods. 2019 Apr 1;317:94-107. doi: 10.1016/j.jneumeth.2019.02.009. Epub 2019 Feb 17.

PMID:
30786248
19.

MRI detects peripheral nerve and adjacent muscle pathology in non-systemic vasculitic neuropathy (NSVN).

Schneider C, Sprenger A, Weiss K, Slebocki K, Maintz D, Fink GR, Henning TD, Lehmann HC, Lichtenstein T.

J Neurol. 2019 Apr;266(4):975-981. doi: 10.1007/s00415-019-09224-0. Epub 2019 Feb 14.

PMID:
30762104
20.

Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control.

Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, Timmermann L, Fink GR, Drzezga A, Eggers C, van Eimeren T.

Brain. 2019 Mar 1;142(3):733-743. doi: 10.1093/brain/awz007.

PMID:
30753324
21.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

22.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

PMID:
30719763
23.

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients.

Lohmann P, Werner JM, Shah NJ, Fink GR, Langen KJ, Galldiks N.

Cancers (Basel). 2019 Jan 29;11(2). pii: E153. doi: 10.3390/cancers11020153. Review.

24.

Neural Network Connectivity During Post-encoding Rest: Linking Episodic Memory Encoding and Retrieval.

Risius OJ, Onur OA, Dronse J, von Reutern B, Richter N, Fink GR, Kukolja J.

Front Hum Neurosci. 2019 Jan 9;12:528. doi: 10.3389/fnhum.2018.00528. eCollection 2018.

25.

Excised linear introns regulate growth in yeast.

Morgan JT, Fink GR, Bartel DP.

Nature. 2019 Jan;565(7741):606-611. doi: 10.1038/s41586-018-0828-1. Epub 2019 Jan 16.

26.

Effects of a Cognitive Training With and Without Additional Physical Activity in Healthy Older Adults: A Follow-Up 1 Year After a Randomized Controlled Trial.

Kalbe E, Roheger M, Paluszak K, Meyer J, Becker J, Fink GR, Kukolja J, Rahn A, Szabados F, Wirth B, Kessler J.

Front Aging Neurosci. 2018 Dec 18;10:407. doi: 10.3389/fnagi.2018.00407. eCollection 2018.

27.

Cloud-based relational database for multimodal animal data.

Pallast N, Wieters F, Nill M, Fink GR, Aswendt M.

Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay124.

28.

Freely chosen and instructed actions are terminated by different neural mechanisms revealed by kinematics-informed EEG.

Viswanathan S, Wang BA, Abdollahi RO, Daun S, Grefkes C, Fink GR.

Neuroimage. 2019 Mar;188:26-42. doi: 10.1016/j.neuroimage.2018.12.005. Epub 2018 Dec 3.

PMID:
30521953
29.

Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.

Ladwig A, Rogall R, Hucklenbroich J, Willuweit A, Schoeneck M, Langen KJ, Fink GR, Adele Rueger M, Schroeter M.

J Neuroimmune Pharmacol. 2019 Jun;14(2):295-311. doi: 10.1007/s11481-018-9826-1. Epub 2018 Nov 28.

PMID:
30488353
30.

Preserved but Less Efficient Control of Response Interference After Unilateral Lesions of the Striatum.

Schmidt CC, Timpert DC, Arend I, Vossel S, Dovern A, Saliger J, Karbe H, Fink GR, Henik A, Weiss PH.

Front Hum Neurosci. 2018 Oct 16;12:414. doi: 10.3389/fnhum.2018.00414. eCollection 2018.

31.

Functional Connectivity Changes of Key Regions for Motor Initiation in Parkinson's Disease.

Hensel L, Hoffstaedter F, Caspers J, Michely J, Mathys C, Heller J, Eickhoff CR, Reetz K, Südmeyer M, Fink GR, Schnitzler A, Grefkes C, Eickhoff SB.

Cereb Cortex. 2019 Jan 1;29(1):383-396. doi: 10.1093/cercor/bhy259.

32.

Differential Effect of Retroactive Interference on Object and Spatial Memory in the Course of Healthy Aging and Neurodegeneration.

Muecke H, Richter N, von Reutern B, Kukolja J, Fink GR, Onur OA.

Front Aging Neurosci. 2018 Oct 23;10:333. doi: 10.3389/fnagi.2018.00333. eCollection 2018.

33.

Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial.

Kruppa JA, Gossen A, Oberwelland Weiß E, Kohls G, Großheinrich N, Cholemkery H, Freitag CM, Karges W, Wölfle E, Sinzig J, Fink GR, Herpertz-Dahlmann B, Konrad K, Schulte-Rüther M.

Neuropsychopharmacology. 2019 Mar;44(4):749-756. doi: 10.1038/s41386-018-0258-7. Epub 2018 Nov 2.

PMID:
30390065
34.

Galectin-3 Regulates γ-Herpesvirus Specific CD8 T Cell Immunity.

Kaur M, Kumar D, Butty V, Singh S, Esteban A, Fink GR, Ploegh HL, Sehrawat S.

iScience. 2018 Nov 30;9:101-119. doi: 10.1016/j.isci.2018.10.013. Epub 2018 Oct 17.

35.

FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.

Lohmann P, Stavrinou P, Lipke K, Bauer EK, Ceccon G, Werner JM, Neumaier B, Fink GR, Shah NJ, Langen KJ, Galldiks N.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):591-602. doi: 10.1007/s00259-018-4188-8. Epub 2018 Oct 16.

PMID:
30327856
36.

On the Extraction and Analysis of Graphs From Resting-State fMRI to Support a Correct and Robust Diagnostic Tool for Alzheimer's Disease.

Bachmann C, Jacobs HIL, Porta Mana P, Dillen K, Richter N, von Reutern B, Dronse J, Onur OA, Langen KJ, Fink GR, Kukolja J, Morrison A.

Front Neurosci. 2018 Sep 28;12:528. doi: 10.3389/fnins.2018.00528. eCollection 2018.

37.

Effects of serotonin depletion and dopamine depletion on bimodal divided attention.

Königschulte W, Civai C, Hildebrand P, Gaber TJ, Fink GR, Zepf FD.

World J Biol Psychiatry. 2018 Oct 8:1-37. doi: 10.1080/15622975.2018.1532110. [Epub ahead of print]

PMID:
30295116
38.

Extracranial Metastases of a Cerebral Glioblastoma: A Case Report and Review of the Literature.

Rosen J, Blau T, Grau SJ, Barbe MT, Fink GR, Galldiks N.

Case Rep Oncol. 2018 Aug 28;11(2):591-600. doi: 10.1159/000492111. eCollection 2018 May-Aug.

39.

Recovery from apraxic deficits and its neural correlate.

Kusch M, Schmidt CC, Göden L, Tscherpel C, Stahl J, Saliger J, Karbe H, Fink GR, Weiss PH.

Restor Neurol Neurosci. 2018;36(6):669-678. doi: 10.3233/RNN-180815.

PMID:
30282379
40.

Biosynthesis of monoethylene glycol in Saccharomyces cerevisiae utilizing native glycolytic enzymes.

Uranukul B, Woolston BM, Fink GR, Stephanopoulos G.

Metab Eng. 2019 Jan;51:20-31. doi: 10.1016/j.ymben.2018.09.012. Epub 2018 Sep 27.

PMID:
30268818
41.

Predicting IDH genotype in gliomas using FET PET radiomics.

Lohmann P, Lerche C, Bauer EK, Steger J, Stoffels G, Blau T, Dunkl V, Kocher M, Viswanathan S, Filss CP, Stegmayr C, Ruge MI, Neumaier B, Shah NJ, Fink GR, Langen KJ, Galldiks N.

Sci Rep. 2018 Sep 6;8(1):13328. doi: 10.1038/s41598-018-31806-7.

42.

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis.

Lohmann P, Kocher M, Ceccon G, Bauer EK, Stoffels G, Viswanathan S, Ruge MI, Neumaier B, Shah NJ, Fink GR, Langen KJ, Galldiks N.

Neuroimage Clin. 2018 Aug 19;20:537-542. doi: 10.1016/j.nicl.2018.08.024. eCollection 2018.

43.

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease.

Barbe MT, Barthel C, Chen L, Van Dyck N, Brücke T, Seijo F, San Martin ES, Haegelen C, Verin M, Amarell M, Gill S, Whone A, Porta M, Servello D, Fink GR, Alesch F, Bloem BR, Timmermann L.

Brain Stimul. 2018 Nov - Dec;11(6):1404-1406. doi: 10.1016/j.brs.2018.08.016. Epub 2018 Aug 27. No abstract available.

44.

Clinical Outcome After Mechanical Thrombectomy in Patients with Diabetes with Major Ischemic Stroke of the Anterior Circulation.

Borggrefe J, Glück B, Maus V, Onur Ö, Abdullayev N, Barnikol U, Kabbasch C, Fink GR, Mpotsaris A.

World Neurosurg. 2018 Dec;120:e212-e220. doi: 10.1016/j.wneu.2018.08.032. Epub 2018 Aug 16.

PMID:
30121406
45.

[Transition from neuropediatrics to neurology in neuromuscular diseases].

Schara U, Fink GR, von Moers A.

Nervenarzt. 2018 Oct;89(10):1123-1130. doi: 10.1007/s00115-018-0585-2. Review. German.

PMID:
30120487
46.

Directing Neuronal Outgrowth and Network Formation of Rat Cortical Neurons by Cyclic Substrate Stretch.

Abraham JA, Linnartz C, Dreissen G, Springer R, Blaschke S, Rueger MA, Fink GR, Hoffmann B, Merkel R.

Langmuir. 2019 Jun 11;35(23):7423-7431. doi: 10.1021/acs.langmuir.8b02003. Epub 2018 Aug 28.

PMID:
30110535
47.

Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.

Dafsari HS, Ray-Chaudhuri K, Mahlstedt P, Sachse L, Steffen JK, Petry-Schmelzer JN, Dembek TA, Reker P, Barbe MT, Visser-Vandewalle V, Fink GR, Timmermann L.

Eur J Neurol. 2019 Feb;26(2):222-e17. doi: 10.1111/ene.13773. Epub 2018 Sep 21.

PMID:
30107062
48.

Access to End-of Life Parkinson's Disease Patients Through Patient-Centered Integrated Healthcare.

Eggers C, Dano R, Schill J, Fink GR, Timmermann L, Voltz R, Golla H, Lorenzl S.

Front Neurol. 2018 Jul 30;9:627. doi: 10.3389/fneur.2018.00627. eCollection 2018.

49.

Neurocardiac prodrome in LGI1-antibody-negative non-paraneoplastic limbic encephalitis.

Kaluschke T, Johannis W, Mpotsaris A, Fink GR, Malter MP.

J Neurol Sci. 2018 Aug 15;391:12-14. doi: 10.1016/j.jns.2018.05.014. Epub 2018 May 18. No abstract available.

PMID:
30103960
50.

The plasticity of primary microglia and their multifaceted effects on endogenous neural stem cells in vitro and in vivo.

Vay SU, Flitsch LJ, Rabenstein M, Rogall R, Blaschke S, Kleinhaus J, Reinert N, Bach A, Fink GR, Schroeter M, Rueger MA.

J Neuroinflammation. 2018 Aug 13;15(1):226. doi: 10.1186/s12974-018-1261-y.

Supplemental Content

Support Center